Related Experiment Video
Updated: Jan 11, 2026

A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit
Published on: July 13, 2019
Contrast-Linked Pseudomonas Outbreak in a Cardiac Catheterization Laboratory: Case Series and Quality-Improvement
Asadullah Bugti1, Muhammad Kashif2, Nousheen Aijaz3
1Department of Cardiology, Tabba Heart Institute, Karachi, Pakistan.
Background:
Infection control breaches in cardiac catheterization laboratories are rare but may lead to severe consequences. Despite being a high-volume center and an award-winning participant in the national cardiovascular data registry Chest Pain MI registry, Tabba Heart Institute experienced a cluster of Pseudomonas aeruginosa infections after coronary procedures.
Project Rationale:
The outbreak posed significant risks to patient safety and institutional benchmarks, prompting an urgent investigation.
Project Summary:
Between December 2024 and January 2025, 5 patients developed postprocedural complications, 3 of whom had culture-proven P. aeruginosa bloodstream infections, including one fatality. A multidisciplinary team initiated a root cause analysis. Initial infection-control measures failed to prevent further cases. Expanded microbiological testing identified contaminated contrast media as the source. Withdrawal of the implicated product halted new infections. This investigation underscores the importance of stringent surveillance, supply chain oversight, and product sterility verification.
Take-Home Messages:
Even sealed consumables can harbor life-threatening pathogens. Proactive sterility validation and vendor oversight are essential in high-risk procedural environments.
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Cardiac Catheterization IV: Nursing Management
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Acute Pyelonephritis II: Diagnostic Studies and Management
Endocarditis I: Introduction

